Early Treatment of Hepatitis C Virus in Australia [ 2011 - 2014 ]

Research Grant

Researchers: Dr Joseph Doyle (Principal investigator)

Brief description Hepatitis C affects between 1-3% of Australians. Currently, there is no effective vaccine and only 30% will spontaneously clear infection, while the remained develop a chronic disease with a small risk of progression to liver cirrhosis and liver cancer over time. This study aims to evaluate the safety and efficacy of a two different treatment regimens among individuals with recent Hepatitis C infection; and define the risk factors and natural history of Hepatitis C superinfection during treatment.

Funding Amount $AUD 113,322.59

Funding Scheme Postgraduate Scholarships

Notes Medical Postgraduate Scholarship